Table 2 Comparison of mutations found and overall performance between cytology slides and supernatants

From: The value of mutational profiling of the cytocentrifugation supernatant fluid from fine-needle aspiration of pancreatic solid mass lesions

  

Microdissected cytology slides

Cytocentrifugation supernatant

Comparison of mutations

Sample

Cytological diagnosis

KRAS mutations a

LOH

KRAS mutations a

LOH

between found in slides versus supernatant

1

Adenocarcinoma

KRAS 12V low clonality

No LOH

KRAS 12V low clonality

22q low clonality

Additional mutations detected

2

Adenocarcinoma

KRAS 12V low clonality

5q high clonality, 3p low clonality, 17p low clonality

KRAS 12V low clonality

5q high clonality, 3p low clonality, 9p low clonality, 17p low clonality, 17q low clonality

Additional mutations detected

3

Adenocarcinoma

No mutations

17p low clonality, 21q low clonality

No mutations

17p high clonality, 21q high clonality, 5q low clonality

Higher mutation clonality and additional mutations detected

4

Adenocarcinoma

No mutations

No LOH

KRAS 12R low clonality

17p high clonality, 5q low clonality

Additional mutations detected

5

Adenocarcinoma

KRAS 12D low clonality

1p low clonality, 22q low clonality

KRAS 12D high clonality

1p high clonality, 9p high clonality, 17q high clonality, 10q low clonality

Higher mutation clonality and additional mutations detected

6

Mucinous

Not tested

Not tested

No mutations

9q high clonality

N/A

7b

Mucinous

KRAS 12D high clonality

9p high clonality, 10q high clonality, 3p low clonality

KRAS 12D high clonality

9p high clonality, 10q high clonality, 3p low clonality, 5q low clonality

Additional mutations detected

8b

Mucinous

KRAS 12D high clonality

9p high clonality, 10q high clonality, 3p low clonality

KRAS 12D high clonality,

9p high clonality, 10q high clonality, 3p low clonality, 5q low clonality

Additional mutations detected

9

Mucinous

No mutations

9p high clonality

No mutations

9p high clonality

Equivalent

10

Mucinous

Not tested

Not tested

KRAS 12V low clonality

No LOH

N/A

11

Neuroendocrine

No mutations

3p high clonality, 9p low clonality

No mutations

3p high clonality, 9p high clonality

Equivalent

12

Pancreatitis

No mutations

No LOH

No mutations

No LOH

Equivalent

13

Pancreatitis

No mutations

No LOH

No mutations

No LOH

Equivalent

14

Pancreatitis

No mutations

No LOH

No mutations

No LOH

Equivalent

15

Pancreatitis

No mutations

No LOH

No mutations

No LOH

Equivalent

16

Pancreatitis

No mutations

Failed PCR

No mutations

No LOH

Equivalent

17

Negative

No mutations

No LOH

No mutations

No LOH

Equivalent

18

Negative

Not tested

Not tested

No mutations

No LOH

N/A

19

Negative

No mutations

No LOH

No mutations

No LOH

Equivalent

20

Negative

No mutations

No LOH

No mutations

No LOH

Equivalent

21

Suboptimal

No mutations

No LOH

No mutations

No LOH

Equivalent

22

Suboptimal

Failed PCR

Failed PCR

No mutations

No LOH

Improved performance

23

Suboptimal

KRAS 12C low clonality

Failed PCR

KRAS 12C low clonality, KRAS 12V low clonality

No LOH

Improved performance and additional mutations detected

  1. aKRAS point mutations denote codon 12 amino-acid substitutions. Mutations were classified as ‘low clonality’, when the mutation was present in <75% of the DNA, or ‘high clonality’, when the mutation was present in >75% of the DNA.
  2. bSamples belonging to the same patient, obtained at different times.